Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.38.3331
Full Text
Open PDFAbstract
Available in full text
Date
January 10, 2013
Authors
Publisher
American Society of Clinical Oncology (ASCO)